19.20PLN+10.09%Mkt Cap: 102.12M $P/E: —1d ago
Ryvu Therapeutics S.A., a clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally. The company's l…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap102.12M $
Enterprise Value109.96M $
Revenue (TTM)22.38M $
Gross Profit12.02M $
Net Income (TTM)-25.64M $
Revenue/Share0.9682 USD
Last Price19.20 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees228
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLSELVT00013
Valuation
P/E (Trailing)—
P/E (Forward)-8.46
PEG—
EV/EBITDA-5.95
EV/Revenue4.91
P/S4.97
P/B10.63
EPS (TTM)-3.80
EPS (Forward)—
52W Range
13.6429% of range32.50
52W High32.50 PLN
52W Low13.64 PLN
Profitability
Gross Margin76.22%
Oper. Margin-57.15%
EBITDA Margin-82.51%
Profit Margin-162.61%
ROE-188.04%
ROA-45.10%
Growth
Revenue Growth3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.90M $
CapEx (TTM)1.89M $
FCF Margin-74.38%
FCF Yield-16.30%
Net Debt3.27M $
Net Debt/EBITDA-0.18
Balance Sheet
Debt/Equity1.33
Current Ratio2.26
Quick Ratio2.04
Book Value/Sh1.787 PLN
Cash/Share3.594 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)33.62 PLN
Upside (mean)+75.1%
Target Range17.00 PLN – 49.10 PLN
PLN17.00+75.1% to meanPLN49.10
# Analysts5
Ownership
Shares Out.23.12M
Float14.49M
Insiders35.02%
Institutions24.19%
Technical
SMA 5015.11 (+27.1%)
SMA 20022.10 (-13.1%)
Beta0.37
S&P 52W Chg19.97%
Avg Vol (30d)72.07K
Avg Vol (10d)55.87K
Technical Indicators
RSI (14)62.0
MACD-0.6729
MACD Signal-1.2192
MACD Hist.+0.5463
BB Upper16.61 PLN
BB Middle14.88 PLN
BB Lower13.15 PLN
BB Width23.25%
ATR (14)0.8426 PLN
Vol Ratio (20d)6.50x